TFAM and colorectal carcinoma: Increased mtDNA content enhances OXPHOS capacity and supports metastatic phenotypes in MSS CRC; conversely, TFAM-mediated mtDNA depletion can promote progression and chemoresistance in MSI CRC — illustrating that mtDNA quantity and regulation modulate metastatic potential via metabolic reprogramming.